Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Tenforde

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021Mark W Tenforde, Samantha M Olson, Wesley H Self, et al.
The New England Journal of Medicine|March 30, 2022
BNT162b2 Protection against the Omicron Variant in Children and AdolescentsAshley M Price, Samantha M Olson, Margaret M Newhams, et al.
Emerging Infectious Diseases|July 5, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020Benjamin D Hallowell, Christina M Carlson, Jesica R Jacobs, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United StatesAaron M Frutos, Ashley M Price, Elizabeth Harker, et al.
Eclinicalmedicine|September 6, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Manish M Patel, Margaret M Newhams, et al.
Nature Communications|July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccinesLi Wang, Markus H Kainulainen, Nannan Jiang, et al.
JAMA|February 24, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R Feldstein, Mark W Tenforde, Kevin G Friedman, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
JAMA Neurology|March 5, 2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory SyndromeKerri L LaRovere, Becky J Riggs, Tina Y Poussaint, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021Mark W Tenforde, Samantha M Olson, Wesley H Self, et al.
The New England Journal of Medicine|March 30, 2022
BNT162b2 Protection against the Omicron Variant in Children and AdolescentsAshley M Price, Samantha M Olson, Margaret M Newhams, et al.
Emerging Infectious Diseases|July 5, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020Benjamin D Hallowell, Christina M Carlson, Jesica R Jacobs, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United StatesAaron M Frutos, Ashley M Price, Elizabeth Harker, et al.
Eclinicalmedicine|September 6, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Manish M Patel, Margaret M Newhams, et al.
Nature Communications|July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccinesLi Wang, Markus H Kainulainen, Nannan Jiang, et al.
JAMA|February 24, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R Feldstein, Mark W Tenforde, Kevin G Friedman, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
JAMA Neurology|March 5, 2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory SyndromeKerri L LaRovere, Becky J Riggs, Tina Y Poussaint, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
Pageof 14